Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators.
Flierl U, Nero TL, Lim B, Arthur JF, Yao Y, Jung SM, Gitz E, Pollitt AY, Zaldivia MT, Jandrot-Perrus M, Schäfer A, Nieswandt B, Andrews RK, Parker MW, Gardiner EE, Peter K.
Flierl U, et al. Among authors: gitz e.
J Exp Med. 2015 Feb 9;212(2):129-37. doi: 10.1084/jem.20140391. Epub 2015 Feb 2.
J Exp Med. 2015.
PMID: 25646267
Free PMC article.